Health insurer Centene to buy smaller rival WellCare for $15.27 billion - Reuters
Health insurer Centene to buy smaller rival WellCare for $15.27 billion - Reuters
U.S. health insurer Centene Corp confirmed on Wednesday that it would buy WellCare Health Plans Inc in a cash-and-stock deal to bulk up its government-backed healthcare business, valuing its smaller rival at $15.27 billion.
Read more...
Contributor
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Industry description
The investment seeks long-term capital appreciation.
The fund seeks to achieve its investment objective by primarily investing in equity, debt, and/or derivative securities of companies that the Adviser expects to benefit from an event catalyst. It may invest significantly in the common stock of and other interests (e.g., warrants) in special purpose acquisition companies or similar special purpose entities that pool funds to seek potential acquisition opportunities (collectively, “SPACs”). The fund may invest in SPACs for a variety of investment purposes, including to achieve income. It is non-diversified.